Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

14 results
Display

Influence of Estrogen and Polyamines on Mifepristone-induced Apoptosis in Prostate Cancer Cells

Choi EK, Song HJ, Park MS, Kim BG

  • Cancer Res Treat.
  • 2004 Feb;36(1):85-90.
PURPOSE: Although androgens are the main steroids controlling the growth of prostate glands, estrogens are also important in the regulation of its growth. Prostate cancer cells, like other cancer cells,...
Radioresponse of Hepatocellular Carcinoma-Treatment of Lymph Node Metastasis

Yoon SM, Kim JH, Choi EK, Ahn SD, Lee SW, Yi BY, Chung YW, Lee YS, Seo DJ

  • Cancer Res Treat.
  • 2004 Feb;36(1):79-84.
PURPOSE: To analyze the radioresponse of hepatocellular carcinomas (HCC), using accurate measurements of the tumor size in extrahepatic lymph node metastasis, and to obtain information for the future treatment of...
The Role of E-cadherin/Beta-catenin Complex and Cyclin D1 in Head and Neck Squamous Cell Carcinoma

Do NY, Park SY, Lim SC

  • Cancer Res Treat.
  • 2004 Feb;36(1):72-78.
PURPOSE: To determine the relationship between expression pattern of E-cadherin, Beta-catenin and cyclin D1, and clinicopathologic parameters in patients with head and neck squamous cell carcinomas (HNSCC). MATERIALS AND METHODS:...
Intrapleural Chemotherapy with Cisplatin and Cytarabine in the Management of Malignant Pleural Effusion

Kim KW, Park SY, Kim MS, Kim SC, Lee EH, Shin SY, Lee JH, Kweon JB, Park K

  • Cancer Res Treat.
  • 2004 Feb;36(1):68-71.
PURPOSE: The purpose of this study was to evaluate the efficacy of intrapleural chemotherapy (IPC) with cisplatin and cytarabine in the management of malignant pleural effusion (MPE) from non-small-cell lung...
A 21-day Schedule of Gemcitabine and Cisplatin Administration in the Treatment of Advanced Non-Small Cell Lung Carcinoma: a Phase II Study

Park JS, Lee CM, Lee SA, Jung CK, Kim SH, Kwon HC, Kim JS, Kim HJ

  • Cancer Res Treat.
  • 2004 Feb;36(1):62-67.
PURPOSE: To evaluate the efficacy and toxicity of gemcitabine and cisplatin combination chemotherapy, we conducted a phase II study of this regimen in patients with advanced non-small cell lung carcinoma...
Reduced Expression of E-cadherin in Human Non-small Cell Lung Carcinoma

Myong NH

  • Cancer Res Treat.
  • 2004 Feb;36(1):56-61.
PURPOSE: E-cadherin, a calcium-dependent cell to cell adhesion molecule, plays a key role in the maintenance of tissue integrity. Reduction or loss of E-cadherin has been reported to have a...
Long-term Results of Proximal and Total Gastrectomy for Adenocarcinoma of the Upper Third of the Stomach

Yoo CH, Sohn BH, Han WK, Pae WK

  • Cancer Res Treat.
  • 2004 Feb;36(1):50-55.
PURPOSE: The choice of surgical strategy for patients with adenocarcinoma of the upper one third of the stomach is controversial. This study was performed to analyze the surgical results of...
The Differential Gene Expression Profiles between Sensitive and Resistant Breast Cancer Cells to Adriamycin by cDNA Microarray

Ahn MJ, Lee KH, Ahn JI, Yu DH, Lee HS, Choi JH, Jang JS, Bae JM, Lee YS

  • Cancer Res Treat.
  • 2004 Feb;36(1):43-49.
PURPOSE: Adriamycin(R) is one of the most commonly used drugs in the treatment of breast cancer. This study was performed to understand the molecular mechanisms of drug resistance in breast...
Expression Profiling of the Cellular Processes in Uterine Leiomyomas: Omic Approaches and IGF-2 Association with Leiomyosarcomas

Bae SM, Kim YW, Lee JM, Namkoong S, Kim CK, Ahn WS

  • Cancer Res Treat.
  • 2004 Feb;36(1):31-42.
PURPOSE: This study utilized both cDNA microarray and 2D protein gel electrophoresis technology to investigate the multiple interactions of the genes and proteins involved in the pathophysiology of uterine leiomyomas....
2001 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 134 Hospitals

Shin HR, Won YJ, Jung KW, Park JG

  • Cancer Res Treat.
  • 2004 Feb;36(1):19-30.
PURPOSE: To estimate the number of cancer cases during 2001, in Korea, through a nationwide hospital based cancer registration by the Korea Central Cancer Registry (KCCR). MATERIALS AND METHODS: One...
Recent Advances in Management of Laryngeal Cancer

Shim YS

  • Cancer Res Treat.
  • 2004 Feb;36(1):13-18.
Laryngeal cancers account for approximately 1.5% (1~2%) of the total cancers in Korea, and 30% of all head and neck cancers, not including thyroid cancer. Early laryngeal cancer is treated...
p63 and p73 in Tumor Suppression and Promotion

McKeon FD

  • Cancer Res Treat.
  • 2004 Feb;36(1):6-12.
The recent discovery of two genes, termed p63 and p73, encoding transcription factors highly homologous to p53 presents unexpected challenges and opportunities for the understanding and treatment of cancers. The...
Issues in the Management of the Upper Third Gastric Cancer

Yang HK

  • Cancer Res Treat.
  • 2004 Feb;36(1):4-5.
No abstract available.
Role of Microarray in Cancer Diagnosis

Kim H

  • Cancer Res Treat.
  • 2004 Feb;36(1):1-3.
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr